Agenus Inc Stock Ownership - Who owns Agenus?

Open Broker Account

Insider buying vs selling

Have Agenus Inc insiders been buying or selling?
Susan B. HirschDirector2022-07-0110,138$1.85
Susan B. HirschDirector2022-04-016,811$2.75
Steven J. OdayChief Medical Officer2022-02-02101,682$2.51
Christine M. KlaskinPFO & PAO2022-02-0229,587$2.51
Garo H. ArmenChairman and CEO2022-02-02237,011$2.51
Steven J. OdayChief Medical Officer2022-01-0638,679$3.06
Susan B. HirschDirector2022-01-034,677$4.01
Susan B. HirschDirector2021-10-013,257$5.76

1 of 1

AGEN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AGEN insiders and whales buy or sell their stock.

AGEN Shareholders

What type of owners hold Agenus Inc stock?
Garo H. Armen35.54%100,633,425$214.35MInsider
State Street Corp8.21%23,243,261$49.51MInstitution
Deep Track Capital LP7.85%22,241,417$47.37MInstitution
Vanguard Group Inc7.48%21,177,555$45.11MInstitution
Blackrock Inc7.43%21,051,701$44.84MInstitution
Incyte Corp5.99%16,972,968$36.15MInsider
Qvt Associates GP LLC2.44%6,915,630$14.73MInsider
Oracle Investment Management Inc1.64%4,656,132$9.92MInstitution
Geode Capital Management LLC1.57%4,435,167$9.45MInstitution
Invus Public Equities LP1.25%3,533,333$7.53MInsider

1 of 3

AGEN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AGEN51.80%46.89%Net BuyingNet Buying
VERA46.10%53.90%Net BuyingNet Selling
CGEM49.26%50.74%Net BuyingNet Selling
ACET71.17%28.83%Net BuyingNet Selling
IPSC36.95%59.45%Net SellingNet Selling

Agenus Stock Ownership FAQ

Who owns Agenus?

Agenus (NASDAQ: AGEN) is owned by 51.80% institutional shareholders, 46.89% Agenus insiders, and 1.31% retail investors. Garo H. Armen is the largest individual Agenus shareholder, owning 100.63M shares representing 35.54% of the company. Garo H. Armen's Agenus shares are currently valued at $197.24M.

If you're new to stock investing, here's how to buy Agenus stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.